Peter Stein, MD
Director, Office of New Drugs, FDA CDER
Reported to Dr. Marks in September 2021 that his office had made clear to Dr. Szarfman that she should not be discussing or providing internal analyses externally.
Timeline appearances (1)
- internal
Marks tells Cavazzoni that Szarfman has been asked to cease and desist on her vaccine analysis.
Quotes (1)
-
"[T]hanks for flagging this – we've made it clear to her that she should not be discussing or providing internal analyses externally, and needs to focus on her assigned work."